CNS leukemia · 9 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
IT Cytarabine and Methotrexate Variant #05 | — | R 86 | 28d | — | — | — | — | — |
IT Methotrexate monotherapy Variant #02 | — | R 1 | — | — | — | — | — | — |
IT Cytarabine, Methotrexate, Prednisone Variant #01 | — | R 0 | — | — | — | — | — | — |
IT Cytarabine and WBRT Variant #01 | — | R 0 | — | — | — | — | — | — |
IT Cytarabine, Methotrexate, Methylprednisolone Variant #01 | — | R 0 | — | — | — | — | — | — |
IT Methotrexate and Hydrocortisone Variant #01 | — | R 0 | — | — | — | — | — | — |
IT Methotrexate and Methylprednisolone Variant #01 | — | R 0 | — | — | — | — | — | — |
IT Methotrexate and WBRT Variant #02 | — | R 0 | — | — | — | — | — | — |
WBRT Variant #01 Partial | — | — | — | — | — | — | — | — |
9 of 9 regimens shown